| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615259 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 18 Pages |
Abstract
CD135 is emerging as a prognostic factor, a new marker for minimal residual disease, and a potential novel therapeutic target of AML.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Eman Z. Kandeel, Ghada El Sayed, Nahla Elsharkawy, Dalia Negm Eldin, Hanan R. Nassar, Dalia Ibrahiem, Randa Amin, Marwa Hanafi, Mohamed Khalil, Azza Kamel,